TCDB » SEARCH

« See all members of the family

8.A.94.1.2 Secreted complement C1q and tumor necrosis factor-related protein 9 of 333 aas and possibly 1 or 2 TMSs. It is a probable adipokine that activates AMPK, AKT, and p44/42 MAPK signaling pathways (Xin et al. 2014). It may have a protective role in cirrhosis progression (Hicks et al. 2017).
Accession Number:	P0C862
Protein Name:	Complement C1q and tumor necrosis factor-related protein 9A
Length:	333
Molecular Weight:	34681.00
Species:	Homo sapiens (Human) [9606]
Number of TMSs:	2
Location¹ / Topology² / Orientation³:	Secreted¹
Substrate

UniProt (Universal Protein Resource)
CDD Search (Conserved Domain Database)

Predict TMSs (Predict number of transmembrane segments)

FASTA formatted sequence

1:	MRIWWLLLAI EICTGNINSQ DTCRQGHPGI PGNPGHNGLP GRDGRDGAKG DKGDAGEPGR 
61:	PGSPGKDGTS GEKGERGADG KVEAKGIKGD QGSRGSPGKH GPKGLAGPMG EKGLRGETGP 
121:	QGQKGNKGDV GPTGPEGPRG NIGPLGPTGL PGPMGPIGKP GPKGEAGPTG PQGEPGVRGI 
181:	RGWKGDRGEK GKIGETLVLP KSAFTVGLTV LSKFPSSDMP IKFDKILYNE FNHYDTAAGK 
241:	FTCHIAGVYY FTYHITVFSR NVQVSLVKNG VKILHTKDAY MSSEDQASGG IVLQLKLGDE 
301:	VWLQVTGGER FNGLFADEDD DTTFTGFLLF SSP

8.A.94.1.2
Secreted complement C1q and tumor necrosis factor-related protein 9 of 333 aas and possibly 1 or 2 TMSs. It is a probable adipokine that activates AMPK, AKT, and p44/42 MAPK signaling pathways (Xin et al. 2014). It may have a protective role in cirrhosis progression (Hicks et al. 2017).

Cross database links:

External Searches:

Analyze:

8.A.94.1.2Secreted complement C1q and tumor necrosis factor-related protein 9 of 333 aas and possibly 1 or 2 TMSs. It is a probable adipokine that activates AMPK, AKT, and p44/42 MAPK signaling pathways (Xin et al. 2014). It may have a protective role in cirrhosis progression (Hicks et al. 2017).

Cross database links:

External Searches:

Analyze:

8.A.94.1.2
Secreted complement C1q and tumor necrosis factor-related protein 9 of 333 aas and possibly 1 or 2 TMSs. It is a probable adipokine that activates AMPK, AKT, and p44/42 MAPK signaling pathways (Xin et al. 2014). It may have a protective role in cirrhosis progression (Hicks et al. 2017).